Literature DB >> 1345869

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1345869

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  113 in total

Review 1.  Contribution of randomised controlled trials to understanding and management of early breast cancer.

Authors:  M Baum; J Houghton
Journal:  BMJ       Date:  1999-08-28

Review 2.  Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

Authors:  N K Wenger; D Grady
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 3.  The economic potential of tamoxifen prophylaxis in breast cancer.

Authors:  J R Butler
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

Review 4.  Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.

Authors:  Shannon Puhalla; Saveri Bhattacharya; Nancy E Davidson
Journal:  Mol Oncol       Date:  2012-02-24       Impact factor: 6.603

5.  Paclitaxel and docetaxel. Innovation, but at what cost?

Authors:  P E Lønning
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

6.  Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis.

Authors:  N Wu; F Fu; L Chen; Y Lin; P Yang; C Wang
Journal:  Clin Transl Oncol       Date:  2019-06-20       Impact factor: 3.405

7.  Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.

Authors:  Vanessa W Lim; Jun Li; Yinhan Gong; Aizhen Jin; Jian-Min Yuan; Eu Leong Yong; Woon-Puay Koh
Journal:  Endocr Relat Cancer       Date:  2014-02-27       Impact factor: 5.678

8.  Estradiol increases ER-negative breast cancer metastasis in an experimental model.

Authors:  Xujuan Yang; Aashvini Belosay; Mengyuan Du; Timothy M Fan; Russell T Turner; Urszula T Iwaniec; William G Helferich
Journal:  Clin Exp Metastasis       Date:  2013-10-05       Impact factor: 5.150

9.  Health-related quality of life in women previously treated for early-stage breast cancer.

Authors:  Wayne A Bardwell; Jacqueline M Major; Cheryl L Rock; Vicky A Newman; Cynthia A Thomson; Janice A Chilton; Joel E Dimsdale; John P Pierce
Journal:  Psychooncology       Date:  2004-09       Impact factor: 3.894

Review 10.  Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.

Authors:  W C Wood
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.